Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up
Bone Marrow Transplant
.
2020 Jun;55(6):1200-1202.
doi: 10.1038/s41409-019-0671-5.
Epub 2019 Sep 16.
Authors
Noam Benyamini
#
1
,
Noa Lavi
#
2
3
,
Tsila Zuckerman
2
3
,
Ariel Aviv
4
,
Jacob M Rowe
2
3
5
,
Tamar Katz
2
3
Affiliations
1
Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. benyaminin@tlvmc.gov.il.
2
Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
3
Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
4
Hematology Unit, HaEmek Medical Center, Afula, Israel.
5
Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.
#
Contributed equally.
PMID:
31527816
DOI:
10.1038/s41409-019-0671-5
No abstract available
Publication types
Letter
MeSH terms
Follow-Up Studies
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma* / therapy
Stem Cell Transplantation
Transplantation Conditioning
Transplantation, Autologous
Treatment Outcome